Oxbridge Re (OXBR) Stock Price, News & Analysis

Company Overview

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents. Oxbridge Re works closely with insurers to structure agreements that align risk retention levels, collateral requirements, and profit-sharing mechanics. These arrangements often feature customized features such as experience refunds, corridor enhancements, and risk corridors, providing clients with flexibility in managing long-term liabilities.

Oxbridge Re serves a diversified client base across North America, focusing primarily on life, annuity, and disability insurance portfolios. Its underwriting team brings experience in actuarial modeling, financial analysis, and regulatory compliance, supporting transactions that span single-life, group life, living benefits, and specialized guarantee products. While relatively new to the public markets, Oxbridge Re has built strategic alliances with financial institutions and reinsurers to broaden its capital resources and co‐reinsurance capabilities.

Governed by a board with backgrounds in insurance operations, capital markets, and risk management, Oxbridge Re emphasizes disciplined underwriting standards and capital-efficient structuring. The company aims to differentiate itself through innovative deal design and responsive client service, positioning its platform to address evolving regulatory requirements and competitive pressures within the reinsurance industry.

Key Stats

• Today's Range: $1.57 to $1.60
• 50-Day Range: $0.85 to $1.70
• 52-Week Range: $0.66 to $2.86
• Volume: 5,094 shs
• Average Volume: 52,512 shs
• Market Capitalization: $12.72 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.00
• Consensus Rating: Hold

Oxbridge Re Stock Analysis - MarketRank™

Oxbridge Re scored higher than 59% of companies evaluated by MarketBeat, and ranked 548th out of 876 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Hold

Consensus Rating

Oxbridge Re has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.

Upside Potential

Oxbridge Re has a consensus price target of $3.00, representing about 91.1% upside from its current price of $1.57.

Amount of Analyst Coverage

Oxbridge Re has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Oxbridge Re are expected to decrease in the coming year, from ($0.04) to ($0.13) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Oxbridge Re is -6.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Oxbridge Re is -6.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Oxbridge Re has a P/B Ratio of 2.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.10% of the float of Oxbridge Re has been sold short.

Short Interest Ratio / Days to Cover

Oxbridge Re has a short interest ratio ("days to cover") of 0.09, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Oxbridge Re has recently decreased by 72.51%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Oxbridge Re does not currently pay a dividend.

Dividend Growth

Oxbridge Re does not have a long track record of dividend growth.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 1.43

News Sentiment

Oxbridge Re has a news sentiment score of 1.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Oxbridge Re this week, compared to 2 articles on an average week.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Oxbridge Re insiders have not sold or bought any company stock.

Percentage Held by Insiders

16.25% of the stock of Oxbridge Re is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

5.64% of the stock of Oxbridge Re is held by institutions.

Company Calendar

• Last Earnings: 3/30/2026
• Today: 7/25/2026
• Next Earnings (Estimated): 8/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: INS - BROKERS
• Sub-Industry: Insurance
• Current Symbol: NASDAQ:OXBR
• CIK: 1584831
• Web: www.oxbridgere.com
• Phone: (345) 749-7570
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Oxbridge Re: $3.00
• High Price Target: $3.00
• Low Price Target: $3.00
• Potential Upside/Downside: +91.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.25)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.08 million
• Net Margins: -76.47%
• Pretax Margin: -141.35%
• Return on Equity: -33.33%
• Return on Assets: -22.04%

Debt

• Debt-to-Equity Ratio: 0.16
• Current Ratio: 8.15
• Quick Ratio: 8.15

Sales & Book Value

• Annual Sales: $2.58 million
• Price / Sales: 4.93
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.78 per share
• Price / Book: 2.01

Miscellaneous

• Outstanding Shares: 8,100,000
• Free Float: 6,785,000
• Market Cap: $12.72 million
• Optionable: Not Optionable
• Beta: 2.01